お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
市場調査レポート
商品コード
942010

糖尿病向け医療装置・医薬品の世界市場 - カテゴリー別 (診断・モニタリング、治療)・疾患の種類別・地域別:市場規模・シェア・将来展望・機会分析

Diabetes Devices and Drugs Market, By Category (Diagnosis and Monitoring, Therapeutics ), By Disease Type, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 183 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.58円
糖尿病向け医療装置・医薬品の世界市場 - カテゴリー別 (診断・モニタリング、治療)・疾患の種類別・地域別:市場規模・シェア・将来展望・機会分析
出版日: 2020年05月20日
発行: Coherent Market Insights
ページ情報: 英文 183 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の糖尿病向け医療装置および医薬品 (診断・モニタリング・治療用) の市場について分析し、疾患・技術の概要や、市場の基本構造および促進・抑制要因、全体的な市場規模の見通し (過去2年間・今後9年間分)、カテゴリー別・疾患の種類別・地域別の詳細動向、主要企業のプロファイル・業績・戦略計画などを調査しております。

第1章 分析目的・前提条件

第2章 市場概略

  • 分析概要
    • 市場の定義と範囲
  • エグゼクティブサマリー
  • COM (Coherent Opportunity Map:市場機会マップ)

第3章 市場のダイナミクス・規制・動向の分析

  • 市場のダイナミクス
    • 市場促進要因
    • 市場抑制要因
    • 市場機会
  • 影響度の分析
  • 近年の主な動き
  • 規制シナリオ
  • PEST分析

第4章 世界の糖尿病向け医療装置・医薬品市場:カテゴリー別

  • イントロダクション
  • 市場シェア:カテゴリー別 (最新値・予測値)
  • 対前年成長率 (YoY):カテゴリー別 (今後9年間分)
  • セグメント別の詳細動向
    • 診断・モニタリング
      • 血糖モニタリング装置
      • その他の検査装置
      • 糖尿病モニタリングのためのソフトウェアプログラム
      • 人工膵臓
    • 治療
      • インスリン
      • インスリン送達
      • 経口血糖降下薬
      • 細胞療法

第5章 世界の糖尿病向け医療装置・医薬品市場:疾患の種類別

  • イントロダクション
  • 市場シェア:疾患の種類別 (最新値・予測値)
  • 対前年成長率 (YoY):疾患の種類別 (今後9年間分)
  • セグメント別の詳細動向
    • 2型糖尿病
    • 1型糖尿病

第6章 世界の糖尿病向け医療装置・医薬品市場:地域別

  • イントロダクション
  • 市場シェア:地域別 (最新値・予測値)
  • 対前年成長率 (YoY):地域別 (今後9年間分)
  • セグメント別の詳細動向
    • 北米
      • 米国
      • カナダ
    • 欧州
      • 英国
      • ドイツ
      • イタリア
      • フランス
      • スペイン
      • ロシア
      • その他の欧州諸国
    • アジア太平洋地域
      • 中国
      • インド
      • 日本
      • ASEAN
      • オーストラリア
      • 韓国
      • その他のアジア太平洋地域諸国
    • ラテンアメリカ
      • ブラジル
      • メキシコ
      • アルゼンチン
      • その他のラテンアメリカ諸国
    • 中東
      • 湾岸協力会議 (GCC) 諸国
      • イスラエル
      • その他の中東諸国
    • アフリカ
      • 北部アフリカ
      • 中部アフリカ
      • 南部アフリカ

第7章 競合情勢

  • 企業プロファイル
    • Abbott Laboratories
      • 会社概要
      • 製品ポートフォリオ
      • 近年の主な動向
      • 財務実績
      • 戦略
    • Bristol-Myers Squibb
    • DexCom, Inc.
    • Eli Lilly and Company
    • Companion Medical
    • GlaxoSmithKline plc
    • Glenmark Pharmaceuticals
    • Johnson & Johnson
    • Lupin Ltd.
    • F. Hoffmann-La Roche AG
    • Sanofi

第8章 付録

目次

Title:
Diabetes Devices and Drugs (Diagnosis, Monitoring, and Therapeutics) Market, By Category (Diagnosis and Monitoring (Blood Glucose Monitoring Devices, Other Testing Devices, Software Programs for Diabetes Monitoring, Artificial Pancreas), Therapeutics (Insulin, Insulin Delivery, Oral Hypoglycemic Agents, Cell Therapies)), By Disease Type (Type 2 Diabetes, Type 1 Diabetes), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Diabetes devices and drugs (diagnosis, monitoring and therapeutics) consists of diabetes management right from diagnosis, monitoring, till treatment. Diabetes is characterized by high presence of blood glucose, also called blood sugar, in the body. There are three main types of diabetes: type 1, type 2, and gestational diabetes. Oral glucose tolerance testing and hemoglobin A1c (HbA1c) testing are some of the tests used in the diagnosis of the chronic condition. Treatment options include use of insulin, oral hypoglycemic agents, and others.

Restraints of the Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market

Lack of awareness about diabetes diagnostics and treatment, especially in emerging economies, is expected to hinder growth of the global diabetes devices and drugs (diagnosis, monitoring, and therapeutics) market. Moreover, recall of diabetes drugs is also expected to limit growth of the market.

Key features of the study:

  • This report provides in-depth analysis of the global diabetes devices and drugs (diagnosis, monitoring and therapeutics) market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020-2027), considering 2019, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global diabetes devices and drugs (diagnosis, monitoring and therapeutics) market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Abbott Laboratories, Bristol-Myers Squibb, DexCom, Inc., Eli Lilly and Company, Companion Medical, GlaxoSmithKline plc, Glenmark Pharmaceuticals, Johnson & Johnson, Lupin Ltd., F. Hoffmann-La Roche AG, and Sanofi.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global diabetes devices and drugs (diagnosis, monitoring and therapeutics) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market, By Category:
    • Diagnosis and Monitoring
  • Blood Glucose Monitoring Devices
  • Other Testing Devices
  • Software Programs for Diabetes Monitoring
  • Artificial Pancreas
    • Therapeutics
  • Insulin
  • Insulin Delivery
  • Oral Hypoglycemic Agents
  • Cell Therapies
  • Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market, By Disease Type:
    • Type 2 Diabetes
    • Type 1 Diabetes
  • Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market, By Geography:
    • North America
  • By Category
    • Diagnosis and Monitoring
      • Blood Glucose Monitoring Devices
      • Other Testing Devices
      • Software Programs for Diabetes Monitoring
      • Artificial Pancreas
    • Therapeutics
      • Insulin
      • Insulin Delivery
      • Oral Hypoglycemic Agents
      • Cell Therapies
  • By Disease Type
    • Type 2 Diabetes
    • Type 1 Diabetes
  • By Country:
    • U.S.
    • Canada
    • Europe
  • By Category
    • Diagnosis and Monitoring
      • Blood Glucose Monitoring Devices
      • Other Testing Devices
      • Software Programs for Diabetes Monitoring
      • Artificial Pancreas
    • Therapeutics
      • Insulin
      • Insulin Delivery
      • Oral Hypoglycemic Agents
      • Cell Therapies
  • By Disease Type
    • Type 2 Diabetes
    • Type 1 Diabetes
  • By Country:
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • By Category
    • Diagnosis and Monitoring
      • Blood Glucose Monitoring Devices
      • Other Testing Devices
      • Software Programs for Diabetes Monitoring
      • Artificial Pancreas
    • Therapeutics
      • Insulin
      • Insulin Delivery
      • Oral Hypoglycemic Agents
      • Cell Therapies
  • By Disease Type
    • Type 2 Diabetes
    • Type 1 Diabetes
  • By Country:
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
  • By Category
    • Diagnosis and Monitoring
      • Blood Glucose Monitoring Devices
      • Other Testing Devices
      • Software Programs for Diabetes Monitoring
      • Artificial Pancreas
    • Therapeutics
      • Insulin
      • Insulin Delivery
      • Oral Hypoglycemic Agents
      • Cell Therapies
  • By Disease Type
    • Type 2 Diabetes
    • Type 1 Diabetes
  • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East:
  • By Category
    • Diagnosis and Monitoring
      • Blood Glucose Monitoring Devices
      • Other Testing Devices
      • Software Programs for Diabetes Monitoring
      • Artificial Pancreas
    • Therapeutics
      • Insulin
      • Insulin Delivery
      • Oral Hypoglycemic Agents
      • Cell Therapies
  • By Disease Type
    • Type 2 Diabetes
    • Type 1 Diabetes
  • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • By Category
    • Diagnosis and Monitoring
      • Blood Glucose Monitoring Devices
      • Other Testing Devices
      • Software Programs for Diabetes Monitoring
      • Artificial Pancreas
    • Therapeutics
      • Insulin
      • Insulin Delivery
      • Oral Hypoglycemic Agents
      • Cell Therapies
  • By Disease Type
    • Type 2 Diabetes
    • Type 1 Diabetes
  • By Country/Region:
    • Central Africa
    • South Africa
    • North Africa
  • Company Profiles
    • Abbott Laboratories *
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
    • Bristol-Myers Squibb
    • DexCom, Inc.
    • Eli Lilly and Company
    • Companion Medical
    • GlaxoSmithKline plc
    • Glenmark Pharmaceuticals
    • Johnson & Johnson
    • Lupin Ltd.
    • F. Hoffmann-La Roche AG
    • Sanofi

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
  • Market Definition and Scope
    • Executive Summary
  • Market Snippet, By Category
  • Market Snippet, By Disease Type
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • PEST Analysis

4. Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market, By Category, 2019 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Diagnosis and Monitoring
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Blood Glucose Monitoring Devices
    • Other Testing Devices
    • Software Programs for Diabetes Monitoring
    • Artificial Pancreas
    • Therapeutics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Insulin
    • Insulin Delivery
    • Oral Hypoglycemic Agents
    • Cell Therapies

5. Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market, By Disease Type, 2019 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Type 2 Diabetes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Type 1 Diabetes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends

6. Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market, By Regions, 2019 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
    • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

7. Competitive Landscape

    • Company Profiles
  • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bristol-Myers Squibb
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • DexCom, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Eli Lilly and Company
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Companion Medical
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GlaxoSmithKline plc
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Glenmark Pharmaceuticals
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson & Johnson
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lupin Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • F. Hoffmann-La Roche AG
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sanofi
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

8. Section

    • References
    • Research Methodology
    • About us and Sales Contact
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.